One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Endothelial dysfunction under the spotlight: mechanisms and novel therapeutic targets
doi : 10.1093/eurheartj/ehag138
Volume 47, Issue 10, 7 March 2026
ESC-JCS Joint Symposium at the 89th Japanese Circulation Society Annual Meeting: focus on angina with non-obstructive coronary arteries
ERC-funded proof of concept grant: targeting imidazoline 1-receptor in atherosclerosis
Endothelial to mesenchymal transition in cardiovascular diseases: molecular insights and clinical perspectives
Semaglutide promotes bone marrow–derived progenitor cell flux towards an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trial
Incretin therapy for cardiovascular disease: opportunities, mechanistic gaps, and challenges
EP4/ANXA2 axis in pulmonary arterial hypertension: therapeutic implications
Revisiting prostaglandin biology in pulmonary arterial hypertension: targeting the EP4/ANXA2 axis
Taurochenodeoxycholic acid alleviates obesity-induced endothelial dysfunction
Atherosclerotic progression at sites of low shear stress is attenuated by myeloid-PlexinD1 deficiency through suppression of classical macrophage polarization
Un-plexing atherosclerosis: how flow shapes arterial inflammation through PlexinD1
Longitudinal surgical trends and methodological constraints in INAA research
Beyond boundaries: towards a global understanding of infected native aortic aneurysms
A tale of two forces: pulmonary hypertension and hepatopulmonary syndrome in congenital portosystemic shunt
Successful endovascular and open repair for brucellosis-associated multiple pseudoaneurysms
Weekly Journal Scan: Exploring the balance of benefits and harms of intensive blood pressure control
